VERU: Veru Inc. Stock

by  •  • Comments Off on VERU: Veru Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 77.32
Enterprise Value ($M) 60.59
Book Value ($M) 26.63
Book Value / Share 0.18
Price / Book 2.90
NCAV ($M) 15.18
NCAV / Share 0.10
Price / NCAV 5.09

Profitability (mra)
Return on Invested Capital (ROIC) -0.96
Return on Assets (ROA) -0.48
Return on Equity (ROE) -0.75

Liquidity (mrq)
Quick Ratio 3.82
Current Ratio 4.47

Balance Sheet (mrq) ($M)
Current Assets 28.38
Assets 39.83
Liabilities 13.20
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 16.89
Operating Income -38.14
Net Income -37.80
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -21.68
Cash from Investing 0.15
Cash from Financing 36.83

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-12 13G/A Adage Capital Partners Gp, L.l.c. 1.57 -83.24
11-12 13G/A Adage Capital Management, L.P. 5.37
11-08 13G BlackRock, Inc. 5.60 0.00
11-04 13G/A Millennium Management Llc 4.00 -22.99
2024-02-14 13G/A Perceptive Advisors Llc 3.80 -28.93

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-12-16 10-K UNITED STATES ‎SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-04-01 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-04-01 10-K/A UNITED STATES ‎SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1)

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-07 133,420 461,707 28.90
2025-03-06 355,715 1,096,351 32.45
2025-03-05 273,524 692,084 39.52
2025-03-04 456,752 1,236,420 36.94

(click for more detail)

Similar Companies
UNCY – Unicycive Therapeutics, Inc. UPC – Universe Pharmaceuticals INC
UPXI – Upexi, Inc. VINC – Vincerx Pharma, Inc.
VKTX – Viking Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io